OutPerformDaily

  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks

Lost Password?
FDA approves Alhemo® as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B (HA/HB) without inhibitors

FDA approves Alhemo® as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B (HA/HB) without inhibitors

Amazon earnings primer: Why AI and tariffs are key to the second quarter

We’re lowering our price target on Bristol Myers as two key overhangs persist

Stock Market Today: Indexes Trim Gains As Core Inflation Exceeds Views; Meta, Carvana Hit New Entries (Live)

Stock Market Today: Indexes Trim Gains As Core Inflation Exceeds Views; Meta, Carvana Hit New Entries (Live)

Roblox stock soars 16% after revenue beat, strong user growth

Microsoft ends tradition of naming competitors in regulatory filings

OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
3rdPartyFeeds • News

Bond Report: 2-year Treasury yield jumps back above 4% after report about First Republic Bank

March 16, 2023

The policy-sensitive 2-year Treasury yield spiked after a report that several big banks are talking about a potential funding deal with First Republic Bank...

3rdPartyFeeds

Dow Jones Falls 225 Points After Surprise Drop In Jobless Claims; First Republic Crashes 35% On Possible Sale

March 16, 2023

The Dow Jones dropped 200 points Thursday on initial jobless claims. Regional bank First Republic plunged 35% on possible sale. Read More...

3rdPartyFeeds

These Stocks Are Moving the Most Today: First Republic, Credit Suisse, Snap, Adobe, Proterra, and More

March 16, 2023

First Republic Bank falls sharply as questions are raised about the bank's future, Credit Suisse will exercise an option to borrow as much as $54 billion from...

3rdPartyFeeds

2 Growth Stocks That Are Trading at a Huge Discount Right Now — Maybe Rightfully So

March 16, 2023

On that note, here are a couple of severely beaten-down growth stocks that are popular among investors, but only one of them has a credible path to stay in...

3rdPartyFeeds

What Meta Platforms and Netflix Investors Should Know About Recent Updates

March 16, 2023

Meta Platforms is expected to lay off an additional 10,000 employees within the next few months in hopes of improving financials and making Facebook one of the...

3rdPartyFeeds • News

Need to Know: Chips, energy and an Amazon rival: Stock picks from a fund manager with three decades of experience

March 16, 2023

The manager of the Plumb Balanced Fund has three stock ideas to share. But first, some timely advice from the manager's three decades of experience. Read More...

3rdPartyFeeds • News

The Margin: Sláinte, retailers! St. Patrick’s Day spending could hit a record $6.9 billion in the U.S.

March 16, 2023

St. Paddy's Day by the numbers: What revelers will spend their money on, how they'll be toasting the holiday, the most Irish county in the country, and more...

3rdPartyFeeds

Dow Jones Futures Fall: Credit Suisse Taps Swiss National Bank; First Republic Dives On Sales Report

March 16, 2023

Credit Suisse borrowed up to $54 billion from the Swiss National Bank after the Nasdaq eked out a gain Wednesday. Read More...

3rdPartyFeeds

China’s alternative to ChatGPT: what we know so far | The Crypto Mile

March 16, 2023

Baidu has launched China's domestic generative AI tool, to rival Microsoft's ChatGPT and Google's Bard. Yahoo Finance UK speaks to artificial intelligence...

3rdPartyFeeds

These Stocks Are Moving the Most Today: Credit Suisse, First Republic, Snap, Adobe, UiPath, and More

March 16, 2023

Credit Suisse will exercise an option to borrow as much as $54 billion from the Swiss National Bank, Snap surges on a report the Biden administration is...

Previous 1 … 1,269 1,270 1,271 1,272 1,273 … 8,320 Next
Indices by TradingView
FDA approves Alhemo® as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B (HA/HB) without inhibitors

FDA approves Alhemo® as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B (HA/HB) without inhibitors

July 31, 2025

Amazon earnings primer: Why AI and tariffs are key to the second quarter

July 31, 2025

We’re lowering our price target on Bristol Myers as two key overhangs persist

July 31, 2025
Stock Market Today: Indexes Trim Gains As Core Inflation Exceeds Views; Meta, Carvana Hit New Entries (Live)

Stock Market Today: Indexes Trim Gains As Core Inflation Exceeds Views; Meta, Carvana Hit New Entries (Live)

July 31, 2025

Roblox stock soars 16% after revenue beat, strong user growth

July 31, 2025

Categories

  • 3rdPartyFeeds
  • Cannabis Stocks
  • Index Funds
  • International
  • News
  • Short
  • Stock Picks
  • Tech Stocks
  • Uncategorized
Indices by TradingView
While subscribers receive the benefit of Outperformdaily opinions, none of the information contained therein constitutes a recommendation from Outperformdaily that any particular security, portfolio of securities, transaction, option, or investment strategy is suitable for any specific person. You further understand that we will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent any of the information contained in Outperformdaily may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Outperformdaily’s past results are not necessarily indicative of future performance. All investments are subject to loss. Our employees and writters typically personally invest in all recommendations, but they are not obligated too. Our employees and writters are prohibited from taking an opposite position from which they write about.